.svg){kind=small}
Dr. Jorg Taubel will be attending the AGAH Annual Meeting. As a pivotal event in the field of clinical pharmacology, the AGAH Annual Meeting brings together experts and professionals from around the world.
Since 1999, these gatherings have been a cornerstone of collaboration with esteemed international partner organisations, including the American College of Clinical Pharmacology (ACCP), the French Club Phase 1, the Belgian Association of Phase-1 Units (BAPU), and the British Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI).
Dr. Taubel's participation underscores our commitment to advancing knowledge and fostering collaboration in clinical pharmacology.
To find out more: https://www.agah.eu/events/annual-meetings/
-min.jpg)
.jpg)
Latest news
Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease
June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read moreA first of a kind trial in the fight against malaria
June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
